Ligand Pharmaceuticals | LGND - Custo de Mercadoria Vendida





Custo de Mercadoria Vendida Alterar Data
Agenus USD 642K 399K 2025-09
Amgen USD 1.6B 187M 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
Baxter International USD 1.93B 118M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Eli Lilly USD 3.58B 205M 2026-03
Enviri Corporation USD 472M 17.65M 2025-12
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 2.07B 192M 2026-06
Glaxosmithkline GBP 1.88B 1.6B 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 49.5M 3.34M 2026-03
Intrexon USD 1.01M 344K 2024-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Ligand Pharmaceuticals USD 11.37M 8.38M 2026-03
MacroGenics USD 9.53M 585K 2026-03
Merck USD 2.94B 380M 2026-03
Pacira USD 50.74M 3.89M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Veracyte USD 42.19M 3.7M 2026-06